T. Nishimura

发表

Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus.

H. Itoh, Masami Tanaka, T. Nishimura, 2015, Journal of diabetes and its complications.

Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus.

H. Itoh, Masami Tanaka, T. Nishimura, 2015, Journal of diabetes and its complications.

Comparison of Glycemic Control Indicators and Safety Evaluation duringLinagliptin Treatment over 6 Months in Japanese Type 2 DiabeticPatients with and without Nephropathy

H. Itoh, Y. Saisho, J. Irie, 2016 .

Serum C-peptide to plasma glucose ratio may be associated with efficacy of vildagliptin in Japanese patients with type 2 diabetes mellitus

H. Itoh, Y. Saisho, J. Irie, 2015, Diabetology International.

Clinical significance of serum complement factor 3 in patients with type 2 diabetes mellitus.

S. Yamashita, K. Azuma, Y. Atsumi, 2017, Diabetes research and clinical practice.

Lower serum total bilirubin concentration is associated with higher prevalence of gestational diabetes mellitus in Japanese pregnant women.

H. Itoh, Y. Saisho, Masami Tanaka, 2018, Endocrine journal.

Bilirubin as a New Biomarker of Diabetes and its MicrovascularComplications

H. Itoh, Masami Tanaka, T. Nishimura, 2016 .

Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.

H. Itoh, Masami Tanaka, A. Ichihara, 2014, Diabetes research and clinical practice.

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.

S. Kihara, S. Yamashita, T. Funahashi, 2001, Diabetes research and clinical practice.

A Reduction of HbA1c after 3 Months Predicts 2-year Responsiveness to Sitagliptin Treatment.

H. Itoh, Y. Saisho, J. Irie, 2015, Internal medicine.

C-peptide immunoreactivity index is associated with improvement of HbA1c: 2-Year follow-up of sitagliptin use in patients with type 2 diabetes.

H. Itoh, Y. Saisho, J. Irie, 2015, Diabetes research and clinical practice.

Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients

H. Itoh, Y. Saisho, J. Irie, 2014, Diabetology & Metabolic Syndrome.

Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease

H. Itoh, Masami Tanaka, T. Nishimura, 2018, Diabetology International.

Hyperhomocysteinemia and Hyperuricemia are Closely Associated with a Decline in Renal Function in Patients with Type 2 Diabetes

H. Itoh, Masami Tanaka, T. Nishimura, 2017 .

Low serum total bilirubin concentration in patients with type 1 diabetes mellitus complicated by retinopathy and nephropathy

H. Itoh, Masami Tanaka, T. Nishimura, 2015, Diabetology International.

Dipeptidyl Peptidase-4 Inhibitor Switching as an Alternative Add-on Therapy to Current Strategies Recommended by Guidelines: Analysis of a Retrospective Cohort of Type 2 Diabetic Patients

H. Itoh, Masami Tanaka, T. Nishimura, 2016 .